SCL binds the human homologue of DRG in vivo

X F Zhao1, P D Aplan

  • 1Departments of Pediatrics and Molecular Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.

Insights

Researchers identified the human development regulated GTP-binding protein (DRG), a suspected oncoprotein. This discovery provides a crucial new target for cancer research and drug development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The human development regulated GTP-binding protein (DRG) is a suspected oncoprotein.
  • Homologues of human DRG exist in various species, including mouse, Xenopus, Drosophila, yeast, and Halobacteria.
  • The precise role and identification of human DRG have remained elusive.

Purpose of the Study:

  • To identify and clone the human homologue of the development regulated GTP-binding protein (DRG).
  • To characterize the cloned human DRG and compare it with its mouse counterpart.
  • To validate the cloned sequence as the bona fide human DRG.

Main Methods:

  • Yeast two-hybrid system was employed to search for SCL binding partners.
  • Isolation of two independent cDNA clones (L51 and V3) from human fetal liver and thymus cDNA libraries.
  • Amino acid sequence comparison between the cloned human DRG and mouse DRG.

Main Results:

  • Two independent cDNA clones representing the human DRG homologue were successfully isolated.
  • The cloned human DRG exhibited high primary amino acid structure conservation with mouse DRG.
  • Only a single amino acid difference was noted between the human and mouse DRG proteins.

Conclusions:

  • The study successfully identified and cloned the bona fide human development regulated GTP-binding protein (DRG).
  • The high degree of conservation suggests a critical and conserved biological function for DRG across species.
  • This finding establishes human DRG as a significant target for future oncogenic and developmental studies.